The Onset of Systemic Oxidative Stress Associated with the Accumulation of Lipid Peroxidation Product Acrolein in the Skin of Patients with Small-Vessel Vasculitis.
Acrolein
/ administration & dosage
Adult
Aged
Aged, 80 and over
Blood Vessels
/ drug effects
Female
Homeostasis
/ drug effects
Humans
Inflammation
/ drug therapy
Lipid Peroxidation
/ drug effects
Male
Middle Aged
Oxidative Stress
/ drug effects
Peroxides
/ metabolism
Skin
/ drug effects
Vasculitis
/ drug therapy
acrolein
lipid peroxidation
oxidative stress
vasculitis
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
17 Apr 2021
17 Apr 2021
Historique:
received:
15
03
2021
revised:
02
04
2021
accepted:
13
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Small-vessel vasculitis (SVV) is the inflammation of the vessel wall that can result in hemorrhage and/or ischemia. Among the histological findings in SVV are increased infiltrating neutrophils, which, due to their oxidative burst and myeloperoxidase activity, release excessive reactive oxygen species, triggering a chain reaction of lipid peroxidation and yielding reactive aldehydes such as acrolein. The implication of oxidative stress in the pathogenesis of SVV was studied, focusing on acrolein immunohistochemistry in the affected skin vessels and systemic stress response. Samples from SVV patients and healthy subjects were collected and analyzed for total serum peroxides, total antioxidant capacity, inflammatory and immunological parameters, as well as for the presence of acrolein-protein adducts in the skin tissue specimens. The obtained data showed that systemic redox homeostasis and iron metabolism are altered in SVV patients. Possible biomarkers in the evaluation of oxidative status, disease activity and prevalence were indicated. Furthermore, a strong correlation between the accumulation of acrolein-protein adducts in the skin and the progression of the disease was revealed. Thus, the results of this study demonstrate that SVV is not only associated with systemic oxidative stress but also with tissue-specific oxidative stress that promotes acrolein formation and protein modification correlating with the severity of cutaneous vasculitis.
Identifiants
pubmed: 33920659
pii: molecules26082344
doi: 10.3390/molecules26082344
pmc: PMC8073584
pii:
doi:
Substances chimiques
Peroxides
0
Acrolein
7864XYD3JJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Am Fam Physician. 2011 Mar 1;83(5):556-65
pubmed: 21391523
Trends Cardiovasc Med. 1999 Jul;9(5):109-13
pubmed: 10639724
Cells. 2019 Mar 29;8(4):
pubmed: 30934946
Antioxidants (Basel). 2020 Feb 25;9(3):
pubmed: 32106528
J Clin Invest. 1984 Jun;73(6):1576-9
pubmed: 6327764
Free Radic Biol Med. 2014 Jun;71:427-436
pubmed: 24561579
J Invest Dermatol. 2007 Feb;127(2):447-54
pubmed: 17008881
Environ Toxicol. 2012 Nov;27(11):644-52
pubmed: 21374787
Arch Dermatol. 1998 Mar;134(3):309-15
pubmed: 9521029
Arch Dermatol. 1971 Sep;104(3):254-9
pubmed: 4398554
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Front Biosci (Landmark Ed). 2016 Jan 01;21:839-55
pubmed: 26709808
Oxid Med Cell Longev. 2018 Nov 8;2018:6375379
pubmed: 30533175
Free Radic Biol Med. 2002 Dec 15;33(12):1651-6
pubmed: 12488133
Clin Exp Immunol. 2012 Nov;170(2):178-85
pubmed: 23039888
J Dermatolog Treat. 2005;16(4):193-206
pubmed: 16249140
Free Radic Biol Med. 2020 Sep;157:128-153
pubmed: 31756524
Reumatizam. 2014;61(1):40-5
pubmed: 25509835
Histopathology. 2010 Jan;56(1):3-23
pubmed: 20055902
J Biol Chem. 2002 Aug 2;277(31):27919-26
pubmed: 12032148
J Clin Invest. 1997 Feb 1;99(3):424-32
pubmed: 9022075
Med Princ Pract. 2017;26(1):1-9
pubmed: 27756061
Circulation. 2003 Oct 7;108(14):1676-8
pubmed: 14504187
Arthritis Rheum. 2007 Jul;56(7):2455-63
pubmed: 17599755
Toxicol In Vitro. 2011 Feb;25(1):160-6
pubmed: 21044880
Croat Med J. 2012 Aug;53(4):304-9
pubmed: 22911521
J Am Acad Dermatol. 2009 Feb;60(2):270-6
pubmed: 19028405
Am J Dermatopathol. 2006 Dec;28(6):486-506
pubmed: 17122493
N Engl J Med. 1997 Nov 20;337(21):1512-23
pubmed: 9366584
Chem Res Toxicol. 2002 Feb;15(2):180-6
pubmed: 11849044
Circulation. 2002 Sep 17;106(12):1439-41
pubmed: 12234944
Am J Dermatopathol. 2005 Dec;27(6):504-28
pubmed: 16314707
Redox Biol. 2015;4:109-17
pubmed: 25553420